In:
Clinical Case Reports, Wiley, Vol. 8, No. 12 ( 2020-12), p. 2641-2644
Abstract:
Eculizumab may be considered as an emergency therapeutic option in refractory life‐threatening warm autoimmune hemolytic anemia especially if direct antiglobulin test is positive for both IgG and C3d and after failure of all conventional treatments.
Type of Medium:
Online Resource
ISSN:
2050-0904
,
2050-0904
Language:
English
Publisher:
Wiley
Publication Date:
2020
detail.hit.zdb_id:
2740234-4